What is the sentiment of this tweet? Please choose an answer from {negative/neutral/positive}.

UPDATE – AffaMed Therapeutics Receives NMPA Approval to Initiate Phase III Clinical Trial in China with Herceptin®… https://t.co/e6GqTwFBn0
neutral